216 related articles for article (PubMed ID: 33563042)
21. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
22. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.
Shen S; Yao T; Xu Y; Zhang D; Fan S; Ma J
Mol Cancer; 2020 Oct; 19(1):151. PubMed ID: 33106166
[TBL] [Abstract][Full Text] [Related]
23. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression.
Gamberi G; Benassi MS; Bohling T; Ragazzini P; Molendini L; Sollazzo MR; Pompetti F; Merli M; Magagnoli G; Balladelli A; Picci P
Oncology; 1998; 55(6):556-63. PubMed ID: 9778623
[TBL] [Abstract][Full Text] [Related]
24. Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.
Wang H; Tang M; Ou L; Hou M; Feng T; Huang YE; Jin Y; Zhang H; Zuo G
Sci Rep; 2017 Jul; 7(1):5382. PubMed ID: 28710380
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
26. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
27. MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.
Ren Z; He M; Shen T; Wang K; Meng Q; Chen X; Zhou L; Han Y; Ji C; Liu S; Fu Q
Cancer Biol Ther; 2020; 21(3):231-240. PubMed ID: 31718519
[TBL] [Abstract][Full Text] [Related]
28. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential crucial genes and key pathways in osteosarcoma.
Liu J; Wu S; Xie X; Wang Z; Lei Q
Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
[TBL] [Abstract][Full Text] [Related]
30. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
[TBL] [Abstract][Full Text] [Related]
31. Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.
Song YJ; Xu Y; Deng C; Zhu X; Fu J; Chen H; Lu J; Xu H; Song G; Tang Q; Wang J
Front Immunol; 2021; 12():623762. PubMed ID: 33959121
[TBL] [Abstract][Full Text] [Related]
32. Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma.
McManus M; Kleinerman E; Yang Y; Livingston JA; Mortus J; Rivera R; Zweidler-McKay P; Schadler K
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786411
[TBL] [Abstract][Full Text] [Related]
33. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
34. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
[TBL] [Abstract][Full Text] [Related]
35. Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15.
Jiang J; Qu H; Zhan X; Liu D; Liang T; Chen L; Huang S; Sun X; Chen J; Chen T; Li H; Yao Y; Liu C
Sci Rep; 2023 Mar; 13(1):5255. PubMed ID: 37002245
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
Jin Y; Wang L; Lou H; Song C; He X; Ding M
Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
[TBL] [Abstract][Full Text] [Related]
37. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
38. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.
Xu D; Wang Y; Liu X; Zhou K; Wu J; Chen J; Chen C; Chen L; Zheng J
Pharmacol Res; 2021 Feb; 164():105370. PubMed ID: 33316381
[TBL] [Abstract][Full Text] [Related]
39. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
40. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
